Plenty of clinical trials (Phase I, II and III) of BTXA™ had been conducted. Subsequently, a series of clinical studies in different areas including neurology, ophthalmology, rehabilitation, pediatrics, gastroenterology, pain management, urology and cosmology were carried out. The global improvement, response onset, efficacy duration, incidence rate and severity of adverse effects of BTXA™ were systematically evaluated in these studies. Thus, BTXA™ are deemed safe and effective in treating various diseases and in many cosmetic uses.
Phase I Clinical Trial
Report of Phase I Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Phase III Clinical Trial
Report of Phase III Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Neurology
Efficacy and Safety of Botulinum Toxin A in Treating Patient with Dystonia and Muscle Spasm of Face: a 10-year Research (Wang Changqing et al)
Rehabilitation
Study of Local Intramuscular Repeated Injection with Botulinum Toxin A for Spasticity of the Upper Limbs in Post-Stroke Patients (Liu Xiaoyan et al)
Gastroenterology
The Treatment of Achalasia of Cardia with Endoscopic Injection of Botulinum Toxin A: An Analysis of 165 Cases (Liu Qingsen et al)
Pain Management
Research Progress on Pain Treatment using Botulinum Toxin Type A (He Lang et al)
Comparative Study
A Double-blind, Randomized, Crossover Study of Prosigne Versus Botox in Patients With Blepharospasm and Hemifacial Spasm (Rieder CRM et al) Comparative Study of Two Types of Botulinum Toxin A (BTXA™) for the Treatment of Facial Wrinkles and Frown Lines (Jairo V et al)
Phase II Clinical Trial
Report of Phase II Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Basic studies
The Structure, Function and the Hot Points in Clinical Use of Botulinum Toxin (Including the Quality of BTXA™) (Wang Yinchun)
Ophthalmology
The Application of Boutlinum Toxin A in the Treatment of Ophthalmology (Wu Xiao)
Pediatrics
Clinical Research of Botulinum Toxin A in the Treatment of Cerebral Palsy (Gao Baoqin et al)
Urology
A Clinical Study on Botulinum A Toxin in Treatment of the Spinal Cord Injury With Neurogenic Bladder (Ao Lijuan et al)
Cosmetology
Treatment of Upper-facial Wrinkles with Botulinum Toxin Type A (BTXA™) in 1000 cases (Yang Honhua)
Phase I Clinical Trial
Report of Phase I Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Phase II Clinical Trial
Report of Phase II Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Phase III Clinical Trial
Report of Phase III Clinical Study of Treatment of Strabismus, Entropion, Blepharospasm and Hemifacial Spasm with BTXA™ (Botulinum Toxin Type A) for Injection
Basic studies
The Structure, Function and the Hot Points in Clinical Use of Botulinum Toxin (Including the Quality of BTXA™) (Wang Yinchun)
Neurology
Efficacy and Safety of Botulinum Toxin A in Treating Patient with Dystonia and Muscle Spasm of Face: a 10-year Research (Wang Changqing et al)
Ophthalmology
The Application of Boutlinum Toxin A in the Treatment of Ophthalmology (Wu Xiao)
Rehabilitation
Study of Local Intramuscular Repeated Injection with Botulinum Toxin A for Spasticity of the Upper Limbs in Post-Stroke Patients (Liu Xiaoyan et al)
Pediatrics
Clinical Research of Botulinum Toxin A in the Treatment of Cerebral Palsy (Gao Baoqin et al)
Gastroenterology
The Treatment of Achalasia of Cardia with Endoscopic Injection of Botulinum Toxin A: An Analysis of 165 Cases (Liu Qingsen et al)
Urology
A Clinical Study on Botulinum A Toxin in Treatment of the Spinal Cord Injury With Neurogenic Bladder (Ao Lijuan et al)
Pain Management
Research Progress on Pain Treatment using Botulinum Toxin Type A (He Lang et al)
Cosmetology
Treatment of Upper-facial Wrinkles with Botulinum Toxin Type A (BTXA™) in 1000 cases (Yang Honhua)
Comparative Study
A Double-blind, Randomized, Crossover Study of Prosigne Versus Botox in Patients With Blepharospasm and Hemifacial Spasm (Rieder CRM et al) Comparative Study of Two Types of Botulinum Toxin A (BTXA™) for the Treatment of Facial Wrinkles and Frown Lines (Jairo V et al)
Join ICBA now for more clinical papers.